Page last updated: 2024-08-21

aminoimidazole carboxamide and Cardiotoxicity

aminoimidazole carboxamide has been researched along with Cardiotoxicity in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Timm, KN; Tyler, DJ1
Huang, Y; Li, Y; Liu, Z; Lu, H; Ma, J; Meng, Y; Wei, Y; Zhang, W; Zhong, K1

Reviews

1 review(s) available for aminoimidazole carboxamide and Cardiotoxicity

ArticleYear
The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity.
    Cardiovascular drugs and therapy, 2020, Volume: 34, Issue:2

    Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Antibiotics, Antineoplastic; Caloric Restriction; Cardiotoxicity; Doxorubicin; Enzyme Activation; Enzyme Activators; Exercise; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metformin; Mitochondria, Heart; Myocytes, Cardiac; Resveratrol; Ribonucleotides; Signal Transduction; Thiazolidinediones

2020

Other Studies

1 other study(ies) available for aminoimidazole carboxamide and Cardiotoxicity

ArticleYear
Development toxicity and cardiotoxicity in zebrafish from exposure to iprodione.
    Chemosphere, 2021, Volume: 263

    Topics: Aminoimidazole Carboxamide; Animals; Cardiotoxicity; Ecosystem; Embryo, Nonmammalian; Embryonic Development; Hydantoins; Oxidative Stress; Zebrafish

2021